The Novel Use of Mitraclip in a Patient with Combined Multiple Myeloma and Heart Failure with Severe Mitral Regurgitation

Oncology patients with Heart Failure (HF) and severe Mitral Regurgitation (MR) are often considered to have a prohibitive risk for surgical mitral valve repair/replacement. We describe a patient with active multiple myeloma and significant HF and MR who was treated with MitraClip, which improved symptoms and allowed delivery of optimal oncological treatment.

Extreme Leukocytosis in a Man after a Half Marathon Race

Leukocytosis is most often defined as an elevated white blood cell count greater than 11.0 × 109 per L in adults, and is a relatively common finding. Normal adult levels of leucocytes is 4.5 to 11.0 × 109 per L. It is of importance for clinicians to be able to distinguish nonmalignant from malignant conditions, and to differentiate between the most common non-malignant causes of leukocytosis. Extreme leukocytosis can be seen in a broad spectrum of clinical conditions in the human body under stress. It is most commonly found in patients suffering from leukemia or severe bacterial infections, but can also be seen in people after hard exercise [1-7]. The present clinical case describes a young healthy man, suffering from extreme leukocytosis after a syncope during a half marathon.